Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoimmunity associated with immunotherapy of cancer.
Amos SM, Duong CP, Westwood JA, Ritchie DS, Junghans RP, Darcy PK, Kershaw MH. Amos SM, et al. Among authors: ritchie ds. Blood. 2011 Jul 21;118(3):499-509. doi: 10.1182/blood-2011-01-325266. Epub 2011 Apr 29. Blood. 2011. PMID: 21531979 Free article. Review.
A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE, Harvey M, Gherardin NA, Koldej R, Huntington N, Neeson P, Trapani JA, Ritchie DS. Davis JE, et al. Among authors: ritchie ds. Biol Blood Marrow Transplant. 2015 Feb;21(2):242-9. doi: 10.1016/j.bbmt.2014.11.003. Epub 2014 Nov 12. Biol Blood Marrow Transplant. 2015. PMID: 25459639 Free article.
MicroRNA as potential biomarkers in Glioblastoma.
Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, Morokoff AP, Kaye AH, Luwor RB. Areeb Z, et al. Among authors: ritchie ds. J Neurooncol. 2015 Nov;125(2):237-48. doi: 10.1007/s11060-015-1912-0. Epub 2015 Sep 21. J Neurooncol. 2015. PMID: 26391593 Review.
P2X7 polymorphisms and stem cell mobilisation.
Koldej R, Collins J, Ritchie D. Koldej R, et al. Leukemia. 2018 Dec;32(12):2724-2726. doi: 10.1038/s41375-018-0232-8. Epub 2018 Aug 8. Leukemia. 2018. PMID: 30089914 No abstract available.
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.
Jiao Y, Davis JE, Rautela J, Carrington EM, Ludford-Menting MJ, Goh W, Delconte RB, Souza-Fonseca-Guimaraes F, Koldej R, Gray D, Huang D, Kile BT, Lew AM, Ritchie DS, Huntington ND. Jiao Y, et al. Among authors: ritchie ds. Cell Death Differ. 2019 Aug;26(8):1516-1530. doi: 10.1038/s41418-018-0228-y. Epub 2018 Nov 12. Cell Death Differ. 2019. PMID: 30420758 Free PMC article.
233 results